Works matching AU Dong Bok Shin


Results: 42
    1
    2

    Efficacy and Safety of FOLFIRI Regimen in Elderly Patients with Metastatic Colorectal or Gastric Cancer.

    Published in:
    Oncologist, 2017, v. 22, n. 3, p. 293, doi. 10.1634/theoncologist.2016-0166
    By:
    • Kim, Ji‐Won;
    • Lee, Keun‐Wook;
    • Kim, Kyu‐Pyo;
    • Lee, Ju Hyun;
    • Hong, Yong Sang;
    • Kim, Jeong‐Eun;
    • Kim, Sun Young;
    • Park, Sook Ryun;
    • Nam, Byung‐Ho;
    • Cho, Sang‐Hee;
    • Chung, Ik‐Joo;
    • Park, Young Suk;
    • Oh, Ho‐Suk;
    • Lee, Myung‐Ah;
    • Kang, Hye Jin;
    • Park, Young Iee;
    • Song, Eun‐Kee;
    • Han, Hye Sook;
    • Lee, Kyu Taeg;
    • Shin, Dong Bok
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 7, p. 7784, doi. 10.1002/cam4.5536
    By:
    • Ryu, Min‐Hee;
    • Lee, Kyung Hee;
    • Shen, Lin;
    • Yeh, Kun‐Huei;
    • Yoo, Changhoon;
    • Hong, Young Seon;
    • Park, Young Iee;
    • Yang, Sung Hyun;
    • Shin, Dong Bok;
    • Zang, Dae Young;
    • Kang, Won Ki;
    • Chung, Ik‐Joo;
    • Kim, Yeul Hong;
    • Ryoo, Baek‐Yeol;
    • Nam, Byung‐Ho;
    • Park, Young Soo;
    • Kang, Yoon‐Koo
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    38

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    39

    Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.

    Published in:
    Acta Oncologica, 2012, v. 51, n. 4, p. 528, doi. 10.3109/0284186X.2011.636753
    By:
    • Kang, Hye Jin;
    • Ryu, Min-Hee;
    • Kim, Kyoung-Mee;
    • Park, Young Soo;
    • Choi, Jene;
    • Ryoo, Baek-Yeol;
    • Kim, Woo Ho;
    • Im, Seock-Ah;
    • Bang, Yung-Jue;
    • Park, Se Hoon;
    • Lee, Jae-Hyuk;
    • Chung, Ik Joo;
    • Bae, Han-Ik;
    • Kim, Jong Gwang;
    • Lee, Kyung Hee;
    • Song, Hong Suk;
    • Kwon, Hyuk-Chan;
    • Baek, Jin Ho;
    • Shin, Dong Bok;
    • Lee, Kyoung Eun
    Publication type:
    Article
    40
    41
    42